Posted on 7/10/17
Poxel Announces Second Quarter 2017 Financial Update
LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, . . .
Posted on 7/10/17
Flexion Therapeutics: Flexin' Its Price Target
Sections What is Flexion Therapeutics (NASDAQ:FLXN) and Zilretta?Why is Zilretta Better?Safety and JAMA ArticleThe Osteoarthritis MarketRisk to RewardFinancialsSummaryWhat is Flexion Therapeutics?Pronounced Flex-shun, the company is based . . .
Posted on 7/10/17
Why Keryx Biopharmaceuticals Stock Soared 11.6% Higher in June
What happenedAfter the biotech issued an update on its first-quarter progress in May, investors continued buying Keryx Pharmaceuticals (NASDAQ:KERX) shares in June, sending them 11.6% higher . . .
Posted on 7/7/17
Why Flexion Therapeutics Rallied 18% in June
What happenedAfter FDA commissioner Scott Gottlieb asked Endo International to voluntarily remove its long-lasting opioid medication Opana ER from the market, and later issued a statement . . .
Posted on 7/7/17
Instant Analysis: Buffett's Berkshire Hathaway to Pull the Trigger on Bank of America Warrants
What happenedWarren Buffett's Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) announced it will exercise its right to buy a whopping 700 million shares of Bank of America (NYSE:BAC) stock. That . . .
Posted on 7/7/17
Warren Buffett Is About to Buy Another Massive Utility -- Here's Why
According to reports, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) is close to finalizing a deal to purchase Texas-based utility Oncor, one of the largest electric utility companies in . . .
Posted on 7/7/17
ProMIS Neurosciences' Sponsored Research Agreement with University of British Columbia Receives Matching Grant from Canadian Institutes of Health Research
ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced that the Company's sponsored research agreement . . .
Posted on 7/7/17
Akebia Closes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 7/7/17
Entasis Therapeutics and the GARDP to Develop a New Treatment for Drug-Resistant Gonorrhea
BOSTON & GENEVA--(BUSINESS WIRE)--Zoliflodacin, a novel first-in-class oral antibiotic and one of the only treatments in development to address the rapidly-growing threat of drug-resistant gonorrhea will . . .
Posted on 7/6/17
Alexion Reaches Funding Agreement with NICE and NHS England
NEW HAVEN, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that it has reached a national funding agreement with the National Institute for Health and Care . . .
Posted on 7/5/17
Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb
Big pharma stocks are arguably set to shine now that the threat of hard caps on drug prices is off the table. Global prescription drug sales, . . .
Posted on 7/5/17
Why Cara Therapeutics Stock Is Crashing
What happenedShares of Cara Therapeutics (NASDAQ:CARA), a clinical-stage biotech, dropped by as much as 28.1% in after-hours trading Thursday, and remain more than 25% lower in . . .
Posted on 7/5/17
How CVS Health Corporation Makes Most of Its Money
CVS Health Corp. (NYSE:CVS) raked in a stunning $177.5 billion last year. To reach this enormous sum, every man, woman, and child in the U.S. would . . .
Posted on 7/4/17
Interleukin Genetics To Explore Strategic Alternatives, Reduce Workforce
WALTHAM, Mass., July 03, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc.(OTCQB:ILIU) today announced that it will pursue strategic alternatives for the Company and will reduce the . . .
Posted on 6/29/17
Baystate Health Named 2017 Premier Alliance Excellence Award Winner
CHARLOTTE, N.C. & SPRINGFIELD, Mass.--(BUSINESS WIRE)--Baystate Health, an academic health system in Springfield, Mass., has received the 2017 Premier Alliance Excellence Award from Premier Inc. (NASDAQ: . . .
Posted on 6/29/17
Melinta Therapeutics Signs $90 Million Financing Agreement with Oberland Capital
New Haven, Conn, June 29, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, has entered into . . .
Posted on 6/29/17
Boston Scientific Corporation (BSX) Investor Presentation - Slideshow
The following slide deck was published by Boston Scientific Corporation in conjunction with this event. 1183READ FULL ARTICLE HERE
Posted on 6/29/17
5 Biotech Stocks With Major Catalysts in July
July brings fireworks and fun for many Americans. The month will also bring major catalysts for several biotechs. Those catalysts could provide a spark for the . . .
Posted on 6/29/17
Aileron Therapeutics Prices IPO
CAMBRIDGE, Mass., June 28, 2017 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a novel class of therapeutics called stapled peptides for cancers . . .
Posted on 6/29/17
Akebia Therapeutics Proposes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 6/28/17
180 Degree Capital Corp.’s Portfolio Company, Mersana Therapeutics Completes IPO
MONTCLAIR, N.J., June 28, 2017 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) noted today that its portfolio company, Mersana Therapeutics, Inc., completed an initial public . . .
Posted on 6/28/17
2 Pharma Buyout Targets That May Surprise You
Mergers and acquisitions can be extremely profitable for pharmaceutical investors. A little over a year ago, for instance, Jazz Pharmaceuticals swooped in to buy Celator Pharmaceuticals . . .
Posted on 6/28/17
Biostage Announces Agreement to Conduct $3.1 Million Private Placement at Market
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus . . .
Posted on 6/28/17
AVEO Oncology Announces $14M in Aggregate Gross Proceeds from Hercules Credit Facility
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced that it has secured $14 million in aggregate gross proceeds through its credit facility with Hercules Capital, Inc. (Hercules) . . .
Posted on 6/28/17
Myomo Announces Publication of Significant Clinical Research
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE MKT: MYO), a commercial stage medical robotics company, today announced publication of an investigator-led clinical study in the Archives of Physical . . .
Boston
